Prospective, Randomized Trial of 3 Rapamycin-Eluting Stents With Different Polymer Coating Strategies For The Reduction of Coronary Restenosis (ISAR-TEST-3)
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2009
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Coronary disorders; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms ISAR-TEST-3
- 31 Mar 2009 Results presented at the 58th Annual Scientific Session of the American College of Cardiology (ACC-2009).
- 10 Jan 2008 Status changed from in progress to completed.
- 26 Oct 2006 New trial record.